Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Erick Awuoche
    Junior Member
    • Oct 2015
    • 2

    #1

    Issue with Randfold p-value in mirdeep2 for non model organism.

    Hello,

    I am facing a challenge with the output of mirdeep2 for non model organism with not previously identified microRNAs. Since my organism of interest has no previously identified microRNAs, I understand that I can use mature microRNA of genetically closer organism to mine. However, when I run this, all the microRNAs identified have a Randfold p-value 'no' suggesting that all those microRNAs predicted in my organism are not real. I think there is problem somewhere which I cannot point at. My script for running this is:

    mapper.pl A.fastq -e -h -i -j -l 18 -r 5 -m -p ./A_index/Amm -s A_collapsed.fa -t A-reads_vs_refdb.arf -v -o 16​

    then
    miRDeep2.pl A_collapsed.fa A.fasta A_collapsed_vs_genome.arf none miRBase_dme_v14.fa none 2>A_report.log​

    Any suggestion here will be appreciated.

    NOTE: I had run another analysis on a different organism with some microRNAs already identified, and the results were fine. Am not sure what is going on in this new one. Any help please.

    Erick

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 11:13 AM
0 responses
16 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, Yesterday, 10:48 AM
0 responses
15 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
35 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...